ERBB2 and breast carcinoma: Accurately distinguishing the HER2 status of breast cancer is crucial to ensuring that patients receive the most appropriate treatment plan for their disease characteristics, maximizing therapeutic efficacy, reducing the risk of recurrence, and improving prognosis (30).